Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene

被引:49
|
作者
Daschner, K
Assum, G
Eisenbarth, I
Krone, W
Hoffmeyer, S
Wortmann, S
Heymer, B
KehrerSawatzki, H
机构
[1] UNIV ULM,ABT HUMANGENET,D-89081 ULM,GERMANY
[2] UNIV ULM,ABT PATHOL,D-89081 ULM,GERMANY
[3] BUNDESWEHRKRANKENHAUS,ABT DERMATOL,ULM,GERMANY
关键词
D O I
10.1006/bbrc.1997.6645
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LOH at the NF1 locus was investigated in 38 neurofibromas of 26 NF1 patients. Only in one of these tumors LOH was observed. In this plexiform neurofibroma of a NF1 patient with a constitutional one basepair insertion in NF1 exon 4b, a non-random X-inactivation pattern was found, strongly suggesting a clonal origin of the tumor cells. The analysis of X-inactivation patterns allowed the classification of some of the other neurofibromas with regard to the detectability of clonal LOH. In 3 of 6 neurofibromas without LOH amenable to this analysis, a comparable X-inactivation pattern was found in constitutional and neurofibroma derived DNA. A clonal LOH would not have been detected in these tumors. However, we observed a nonrandom pattern in 3 of the 6 neurofibromas, suggesting a clonal origin of the tumor cells. LOH was not detected in these tumors, but could, however, have occurred by mutational events below the level of large somatic deletions, loss of a whole chromosome 17 or somatic recombination. (C) 1997 Academic Press.
引用
收藏
页码:346 / 350
页数:5
相关论文
共 50 条
  • [1] Treatment for plexiform neurofibromas in patients with NF1
    Ardern-Holmes, Simone L.
    North, Kathryn N.
    LANCET ONCOLOGY, 2012, 13 (12): : 1175 - 1176
  • [2] Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas
    Kluwe, L
    Friedrich, RE
    Mautner, VF
    CANCER GENETICS AND CYTOGENETICS, 1999, 113 (01) : 65 - 69
  • [3] Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma
    Beert, Eline
    Brems, Hilde
    Renard, Marleen
    Ferreiro, Julio Finalet
    Melotte, Cindy
    Thoelen, Reinhilde
    De Wever, Ivo
    Sciot, Raf
    Legius, Eric
    Debiec-Rychter, Maria
    GENES CHROMOSOMES & CANCER, 2012, 51 (09): : 852 - 857
  • [4] Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells
    Staser, Karl
    Yang, Feng-Chun
    Clapp, David W.
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (04) : 287 - 293
  • [5] EVI2B, a gene lying in an intron of the neurofibromatosis type 1 (NF1) gene, is as the NF1 gene involved in differentiation of melanocytes and keratinocytes and is overexpressed in cells derived from NF1 neurofibromas
    Kaufmann, D
    Gruener, S
    Braun, F
    Stark, M
    Griesser, J
    Hoffmeyer, S
    Bartelt, B
    DNA AND CELL BIOLOGY, 1999, 18 (05) : 345 - 356
  • [7] Somatic loss of the NF1 gene in plexiform neurofibromas in neurofibromatosis type 1.
    Rasmussen, SA
    Colman, SD
    Abernathy, CR
    Muir, D
    Wallace, MR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A80 - A80
  • [8] TRAMETINIB FOR ORBITAL PLEXIFORM NEUROFIBROMAS IN YOUNG CHILDREN WITH NF1
    Toledano, Helen
    Dotan, Gad
    Friedland, Rivka
    Cohen, Rony
    Yassur, Iftach
    Toledano, Hagit
    Constantini, Shlomi
    Rootman, Mika Shapira
    NEURO-ONCOLOGY, 2020, 22 : 418 - 418
  • [9] The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas
    Jackson, Sadhana
    Baker, Eva H.
    Gross, Andrea M.
    Whitcomb, Patricia
    Baldwin, Andrea
    Derdak, Joanne
    Tibery, Cecilia
    Desanto, Jennifer
    Carbonell, Amanda
    Yohay, Kaleb
    O'Sullivan, Geraldine
    Chen, Alice P.
    Widemann, Brigitte C.
    Dombi, Eva
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [10] Association of superficial plexiform and paraspinal neurofibromas in neurofibromatosis 1 (NF1)
    Baser, ME
    Birch, PH
    Evans, DGR
    Friedman, JM
    NEUROLOGY, 1999, 52 (07) : 1519 - 1520